appointment
Idis appoints Richard Greatorex
June 8, 2010Research and Development, Sales and Marketing IDIS, appointment, research and development, sales and marketing
Richard Greatorex has joined specialist medicines supplies company Idis as international marketing manager for its global headquarters in the UK. …
UCB’s Kola joins Astex board
June 5, 2010Research and Development Astex, UCB, appointment, research and development
Dr Ismail Kola has joined the board of directors at UK biotech company Astex Therapeutics. Astex’s non-executive chairman Peter Fellner …
Tim Mustill joins Acumed
June 2, 2010Medical Communications Acumed, KnowledgePoint360, appointment, medical communications
Tim Mustill has been appointed vice-president of client services at Acumed, part of the KnowledgePoint360 medical communications group. He has …
Woolley Pau expands client services department
May 28, 2010Medical Communications Woolley Pau, appointment, medical communications
Woolley Pau has appointed Sarah Philp as a senior account director within its client services department. She has 10 years’ …
Edelman bags the FT’s Stefan Stern
May 27, 2010Medical Communications Edelman, appointment, medical communications
PR agency Edelman has appointed Stefan Stern director of strategy.He will provide senior counsel to the agency’s clients across all …
Pfizer R&D head exits for AstraZeneca
May 27, 2010Research and Development AstraZeneca, Pfizer, appointment, research and development
One of Pfizer’s two heads of research and development Martin Mackay is to leave the company for rivals AstraZeneca. Only …
Takeda appoints Kiyohiko Tamura
May 25, 2010Sales and Marketing Takeda, appointment, sales and marketing
Japanese pharma company Takeda has appointed Kiyohiko Tamura general manager of its newly established Office of the President & CEO. …
Silence Therapeutics promotes Jorg Kaufmann
May 21, 2010Research and Development Silence Therapeutics, appointment, research and development, rnai
Jorg Kaufmann has been made vice president of research at UK biotech company Silence Therapeutics. He previously served as senior …
Jeff Solomon joins Biosciences NEDs
May 20, 2010Business Services Bioscience NEDs, Chairman, Life science, NED, Non Executive Director, appointment, bioscience, business services, recruitment
Jeff Solomon has joined Bioscience NEDs as a non-executive advisor.He is currently chairman of the Council for European Bioregions and a non-executive director …
UCB’s Roch Doliveux joins Innovative Medicines Initiative board
May 19, 2010Research and Development UCB, appointment, research and development
UCB’s chief executive Roch Doliveux has joined the governing board of the Innovative Medicines Initiative. The IMI is a public-private …
Steve Howson to lead Ferring UK
May 18, 2010Research and Development, Sales and Marketing Ferring, appointment, research and development, sales and marketing
Ferring UK has appointed Steve Howson as its new general manager. He will have responsibility for operations in the UK …
UK appoints interim chief medical officer
May 18, 2010NHS, UK, appointment
Professor Dame Sally Davies will take on the role of interim chief medical officer when Sir Liam Donaldson retires as …
Cedra appoints Anthony Busa
May 14, 2010Research and Development CRO, Cedra, appointment, research and development
Phase I clinical trial specialist Cedra Corp division has appointed Anthony Busa as its new permanent chief executive, replacing acting …
Phillipe Lutz joins Telormedix
May 13, 2010Research and Development appointment, research and development, telormedix
Swiss clinical stage biopharmaceutical company Telormedix has appointed Phillipe Lutz chief financial officer. He joins the company from Synosia Therapeutics, …
Four new hires at Euro RSCG Life Medicom
May 12, 2010Medical Communications appointment, medical communications, medicom
Euro RSCG Life Medicom has four new starters to handle new international and domestic business. They are Antonia Ford (pictured left), …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
